XBIT XBiotech Inc.
Healthcare$2.40-1.23%ClosedMarket Cap: $73.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.55
P/S
0.00
EV/EBITDA
1.06
DCF Value
$4.08
FCF Yield
-57.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-26.1%
ROA
-28.7%
ROIC
-35.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-6.3M | $-5.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-29.8M | $-26.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-55.7M | $-45.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.0M | $-6.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.3M | $-1.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-13.6M | $-10.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.7M | $-10.5M | $— | — |
| FY null | $0.00 | NaN% | $-42.5M | $-38.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.9M | $-5.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-15.0M | $-13.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-10.9M | $-10.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-8.6M | $-4.6M | $-0.15 | — |